|Type||Buy / Hold / Sell|
|Year End 1st Jan||Unit||2019||2020||2021||2022||2023||2024E||2025E||CAGR / Avg|
|Diluted Normalised EPS|
|Op. Cashflow ps|
|Free Cashflow ps|
|Diluted Weighted Average Shares||m|
|Book Value ps|
Kenvue Inc. is a consumer health company. The Company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment product categories include cough, cold and allergy; pain care; and other self-care (digestive health, smoking cessation and other). The Skin Health and Beauty segment's product categories include face and body care and hair, sun, and others. The Essential Health segment's product categories include oral care, baby care and other essential health (women’s health and wound care). Its differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec, and Nicorette. It has a global footprint through which it sells and distributes its product portfolio in more than 165 countries across its four regions. Its network includes 114 distribution centers and 38 customer service centers across all its regions.
As of Today at 18:24 UTC, shares in Kenvue are trading at $20.25. This share price information is delayed by 15 minutes.
Shares in Kenvue last closed at $20.25 and the price had moved by over the past 365 days. In terms of relative price strength the Kenvue share price has matched the S&P500 Index by over the past year.
The overall consensus recommendation for Kenvue is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Kenvue dividend yield is 0.99% based on the trailing twelve month period.
Last year, Kenvue paid a total dividend of $0.20, and it currently has a trailing dividend yield of 0.99%. We do not have any data on when Kenvue is to next pay dividends.
We do not have data on when Kenvue is to next pay dividends. The historic dividend yield on Kenvue shares is currently 0.99%.
To buy shares in Kenvue you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $20.25, shares in Kenvue had a market capitalisation of $38.78bn.
Here are the trading details for Kenvue:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: KVUE
Based on an overall assessment of its quality, value and momentum Kenvue is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Kenvue is $23.67. That is 16.89% above the last closing price of $20.25.
Analysts covering Kenvue currently have a consensus Earnings Per Share (EPS) forecast of $1.26 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Kenvue. Over the past six months, its share price has underperformed the S&P500 Index by -28.98%.
As of the last closing price of $20.25, shares in Kenvue were trading -11.85% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Kenvue PE ratio based on its reported earnings over the past 12 months is 15.95. The shares last closed at $20.25.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Kenvue's directors